Skip to main content
. 2022 Aug 11;16:946879. doi: 10.3389/fnins.2022.946879

Table 4.

Summary of overall analyses of the effects of metformin.

Outcome title No. of studies No. of animals Weighted mean difference Heterogeneity
95% CI P-value I 2 P-value
1 BBB scores 12 198
1.1 BBB scale at day 3 9 164 0.42 [−0.01, 0.85] 0.06 72 0.0004
1.2 BBB scale at day 7 12 198 1.41 [1.01, 1.80] <0.00001 52 0.01
1.3 BBB scale at day 14 11 186 2.69 [1.92, 3.47] <0.00001 82 <0.00001
1.4 BBB scale at day 21 8 120 3.89 [2.50, 5.28] <0.00001 91 <0.00001
1.5 BBB scale at day 28 9 136 3.48 [2.04, 4.92] <0.00001 94 <0.00001
2 Inclined plane test 5 68
2.1 Inclined plane test at day 3 4 46 1.00 [0.42, 1.58] 0.0008 0 0.63
2.2 Inclined plane test at day 7 5 68 1.18 [0.23, 2.12] 0.01 48 0.08
2.3 Inclined plane test at day 14 5 68 3.97 [0.84, 7.09] 0.01 88 <0.00001
2.4 Inclined plane test at day 21 4 52 6.97 [2.61, 11.33] 0.002 90 <0.00001
2.5 Inclined plane test at day 28 5 68 7.95 [3.33, 12.57] 0.0007 94 <0.00001
3 Tissue preservation area 4 54 13.29 [2.66, 23.93] 0.01 98 <0.00001
4 Number of anterior horn motor neurons 4 32 14.71 [3.30, 26.12] 0.01 97 <0.00001